News and Events
28.04.2022 News
Indivumed Expands Its Certified Provider Portfolio
Today, we are happy to announce that Indivumed is now a “Certified Service Provider” of the Spatial Transcriptomics technology (Visium Spatial Gene Expression) by 10x Genomics not only for fresh frozen- but for FFPE tissue as well.
Indivumed Expands Its Certified Provider Portfolio Mehr erfahren05.04.2022 Presse
Indivumed Celebrates 20th Anniversary
Indivumed GmbH today celebrated the company’s 20th anniversary milestone. Founded in Hamburg, Germany on April 5, 2002, Indivumed has rapidly expanded to become a leading innovator in the field of precision oncology.
Indivumed Celebrates 20th Anniversary Mehr erfahren17.01.2022 Presse
Indivumed receives EU funding from ERDF structural fund
Indivumed receives EU funding from ERDF structural fund
Indivumed receives EU funding from ERDF structural fund Mehr erfahren12.12.2021 News
Indivumed appoints Dr. Stephan Schüller as CFO
Indivumed is pleased to announce that Dr. Stephan Schüller has joined Indivumed as Chief Financial Officer. With more than 30 years of experience as a business executive, professor, and board member, Dr. Schüller brings highly valuable knowledge and perspectives to Indivumed.
Indivumed appoints Dr. Stephan Schüller as CFO Mehr erfahrenResearch Publications
Product Information
Biospecimen Products
To meet all your needs in cancer research and drug development we offer you a broad spectrum of high-quality biospecimen samples including clinical data.
Applications and CRO Services
To further support your efforts in personalized oncology we offer you an holistic range of clinical, laboratory, and research services.
Product Profiles
ISO-Certified Expertise
Indivumed GmbH’s long-standing expertise is ISO 9001:2015-certified and includes the collection of biological samples and clinical data (Biobank), research service in the form of immunohistochemistry, analysis of signaling proteins, drug testing, establishment of primary cell cultures and molecular biology, bioinformatic and biomedical data analysis.
Download the ISO-Certificate
Video
Discover more about Indivumed’s work and the future of personalized cancer medicine in the following lectures and videos.
IndivuType
The global multi-omics cancer solution
In Focus:
Precision Oncology – Interview with Prof. Dr. Hartmut Juhl, Indivumed Group
In Focus:
Partnerships – Interview with Prof. Dr. Hartmut Juhl, Indivumed Group
In Focus:
nRavel – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Data Depth – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Data Quality – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Our Vision – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
ASCO 2021 – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
Our Mission – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
IndivuType – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
AI – Interview with John L. Marshall, MD, Georgetown University Hospital
In Focus:
ASCO 2021 – Interview with John L. Marshall, MD, Georgetown University Hospital
In Focus:
Precision Oncology – Interview with John L. Marshall, MD, Georgetown University Hospital
Partners
Global Clinical Network
Global Clinical Network
Interview Prof. Jesus Garcia Foncillas – Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
Global Clinical Network
Interview Dr. Rafael López López – Hospital Clínico Universitario de Santiago, Barcelona, Spain
Global Clinical Network
Interview Dr. Xavier Matias-Guiu – Hospital Universitario Arnau de Vilanova Lleida, Lleida, Spain
Global Clinical Network
Interview Prof. Gerry Melino – Hospital Tor Vergata Italy, Rome, Italy
Global Clinical Network
Interview Prof. Sun Young Rha – Severance Hospital Yonsei University Health System, Seoul, South Korea
Global Clinical Network
Interview Dr. Carlos Sampaio – Clinica AMO Brazil, Salvador, Brazil
Global Clinical Network
Interview Prof. Takayuki Yoshino – National Cancer Center Hospital East Japan, Chiba, Japan
Cooperational Partnerships
Cooperational Partnership
Interview with Roald Forsberg, PhD about Gnosis Partnership – Gnosis Data Analysis
Cooperational Partnership
Interview with Oliver Rinner, PhD about Biognosys Partnership – Biognosys AG
Scientific Lectures
Scientific Lectures
22CEMIT Symposium: Overview and Perspectives for Translating Multi-omics into Clinical Utility in Solid Tumors
Speaker: Prof. Dr. Hartmut Juhl
Scientific Lectures
Next In Personalized Medicine - Cancer-Phenotyping
Speaker: Hartmut K. Land, Ph.D., Prof. Dr. Hartmut Juhl
Scientific Lectures
Personalized Oncology – Why Tissue Is the Issue When Characterizing Tumor Expression
Speaker: Dr. Bernd Gromoll, Prof. Dr. Hartmut Juhl
Scientific Lectures
Opening Remarks and The Importance of Biobanking on Personalized Medicine
Speaker: Carolyn Compton, M.D., PhD
Scientific Lectures
The Challlenge and Importance of Standardizing Pre-Analytical Variables in Surgical Pathology Specimens for Clinical Care and Translational Research
Speaker: David Hicks, M.D.
Scientific Lectures
How to Assess Tissue Quality to Improve Tissue Diagnostics
Speaker: Jim Crawford, M.D., PhD
Scientific Lectures
The Future of Personalized Medicine in Oncology Has Begun
Speaker: John Marshall, M.D., PhD
Scientific Lectures
IndivuType: Indivumed's Global Cancer Database Solution for Drug Development and Patient Care
Speaker: Prof. Dr. Hartmut Juhl